Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Specific groups with chronic conditions who could most benefit from RSV prophylaxis
A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.
Food Insecurity and the Dangers of Infant Formula Dilution
US measles cases reach new record high since eradication declaration in 2000
A week into July 2025, the total reported cases in the United States have surpassed the peak of 1274 cases recorded for all 2019.
Demystifying Infant Formula
FDA approves sebetralstat as first and only on-demand treatment for HAE
Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.
Weekly review: Label changes to maralixibat, pediatric mental health data, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.